Recommends Advancing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recommends Advancing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recommends Advancing Today - Breaking & Trending Today

Genprex Announces Safety Review Committee Approves Dose Escalation in Acclaim-1 Phase 1/2 Trial of REQORSA™ in Combination with Tagrisso® in Non-Small Cell Lung Cancer

Published: August 15, 2022

/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...

Source: prnewswire.com

Related Topics:

United StatesAstrazeneca TagrissoMark BergerGenprex IncMerck Co KeytrudaDrug AdministrationExchange CommissionSafety Review CommitteeRecommends AdvancingIncreased DoseSecond CohortFast Track DesignationImmunogene TherapyChief Medical OfficerNanoparticle Delivery SystemPrivate Securities Litigation Reform ActAnnual Report